Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Groupe Oncologie Radiotherapie Tete et Cou
ALX Oncology Inc.
GERCOR - Multidisciplinary Oncology Cooperative Group
City of Hope Medical Center
Institute of Oncology Ljubljana
Rutgers, The State University of New Jersey
Shanghai Jiao Tong University School of Medicine
City Clinical Oncology Hospital No 1
Abramson Cancer Center at Penn Medicine
Wake Forest University Health Sciences
University of Chicago
Eli Lilly and Company
European Organisation for Research and Treatment of Cancer - EORTC
Icahn School of Medicine at Mount Sinai
Masonic Cancer Center, University of Minnesota
Drexel University
Lithuanian University of Health Sciences
SWOG Cancer Research Network
University of Michigan Rogel Cancer Center
Stanford University
University of Chicago
National Cancer Institute (NCI)
University of Chicago
National Cancer Institute (NCI)
National Cancer Institute (NCI)
SWOG Cancer Research Network
SCRI Development Innovations, LLC
Fudan University
SWOG Cancer Research Network
SCRI Development Innovations, LLC
National Cancer Institute (NCI)
Sanofi